[Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol]

Medicina (B Aires). 2004;64(2):152-4.
[Article in Spanish]

Abstract

Fungal endocarditis, in particular due to Candida species, requires medical and surgical treatment and amphotericin B is the drug of choice. Caspofungin is an echinocandin very effective against Candida and Aspergillus. We present a patient with Candida tropicalis endocarditis, fluconazol resistant, treated with caspofungin, on a compassional basis as a result of adverse effects with amphotericin B. The patient had a microbiological response.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antifungal Agents / therapeutic use*
  • Candida tropicalis / drug effects*
  • Candidiasis / complications
  • Candidiasis / drug therapy*
  • Caspofungin
  • Drug Resistance, Fungal
  • Echinocandins
  • Endocarditis / drug therapy*
  • Endocarditis / microbiology
  • Fatal Outcome
  • Fluconazole / therapeutic use*
  • Humans
  • Lipopeptides
  • Male
  • Peptides, Cyclic / therapeutic use*

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Peptides, Cyclic
  • Fluconazole
  • Caspofungin